Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation ESC 2024

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Presenter: David Erlinge

September 02, 2024

Presentation EuroPCR 2023

BIOADAPTOR RCT: Randomized Controlled Trial of Sirolimus-Eluting Bioadaptor Scaffold Versus Zotarolimus-Eluting Drug-Eluting Stent

Presenter: Shigeru Saito

May 18, 2023

Presentation TCT 2020

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

Presenter: Hyo-Soo Kim

October 17, 2020

Presentation

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

February 13, 2017

Presentation TCT 2013

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes(2)

Presenter: Andres I?iguez

October 29, 2013

Presentation TCT 2013

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

Presenter: Andres I?iguez

October 29, 2013

Presentation

Long-term Outcome After Drug-Eluting vs. Bare-Metal Stent Implantation in Patients with STEMI

Presenter: L. Holmvang

June 24, 2013

Presentation

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

Presenter: T. Palmerini

June 04, 2013

Presentation TCT 2013

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization with Drug-Eluting Stent in Patients with Acute Myocardial Infarction

Presenter: Shin Eun Lee, Myung Ho Jeong, Young Jo Kim, Dong Yub Lee, Seong Jung Park

January 31, 2013

Presentation TCT 2013

Impact of Smoking on Outcomes of Acute Myocardial Infarction After Drug-Eluting Stent Implantation: The Smoker’s Paradox

Presenter: Yun-Kyeong Cho, Ji-Hyun Sohn, Hyun-Ok Cho, Hyoung-Seob Park, Hyuck-Jun Yoon, Hyungseop Kim, Chang-Wook Nam, Seung-Ho Hur, Yoon-Nyun Kim, Kwon-Bae Kim

January 31, 2013

Presentation EuroPCR 2012

APPOSITION III: Evaluation of the STENTYS self-apposing bare and drug-eluting stent in 1000 STEMI patients in a real-life setting: in-hospital and 30-day outcomes

Presenter: 166648|giovanni amoroso

May 18, 2012

Presentation TCT 2012

Frequency and Predictors of Drug Eluting Stents Implantation in Patients with Acute Myocardial Infarction - Analysis from the PL-ACS Registry.

Presenter: Marek Gierlotka, Mariusz Gasior, Michal Hawranek, Zbigniew Kalarus, Pawel Buszman, Jacek Legutko, Andrzej Lekston, Lech Polonski

January 03, 2012

Advertisement

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

BIOADAPTOR RCT: Randomized Controlled Trial of Sirolimus-Eluting Bioadaptor Scaffold Versus Zotarolimus-Eluting Drug-Eluting Stent

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes(2)

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

Long-term Outcome After Drug-Eluting vs. Bare-Metal Stent Implantation in Patients with STEMI

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization with Drug-Eluting Stent in Patients with Acute Myocardial Infarction

Impact of Smoking on Outcomes of Acute Myocardial Infarction After Drug-Eluting Stent Implantation: The Smoker’s Paradox

APPOSITION III: Evaluation of the STENTYS self-apposing bare and drug-eluting stent in 1000 STEMI patients in a real-life setting: in-hospital and 30-day outcomes

Frequency and Predictors of Drug Eluting Stents Implantation in Patients with Acute Myocardial Infarction - Analysis from the PL-ACS Registry.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content